Note: Ingredients listed on restricted chemical lists
EC/CAS
200-578-6/64-17-5
Name of the chemical
Ethanol
Concentration
50 - 100
EC/CAS
200-662-2/67-64-1
Name of the chemical
acetone
Concentration
10 - 20
EC/CAS
200-661-7/67-63-0
Name of the chemical
Propan-2-ol
Concentration
2.5 - 10
General Information
Version
107.1
Revision date
2023-03-21
Product name
LP163/93 RI 006
1.2.1 Relevant identified uses
Industrial/Professional use spec
supplier name
Hranipex Ltd
Manufacturer Name
Riepe Gmbh & Co. KG GmbH
Emergency telephone
0344 892 0111, +44 20 7188 7188
Icons in SDS
Company Information
company name
Riepe Gmbh & Co. KG GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@riepe.eu, hranipex@hranipex.cz, hranipex@hranipex.co.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Highly flammable liquid and vapour. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07
Signal word
Danger
Hazard statements
H225 - Highly flammable liquid and vapour. H319 - Causes serious eye irritation.
Precautionary statements
P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P370+P378 - In case of fire: Use carbon dioxide (CO2), extinguishing powder, Water spray or fog to extinguish. P403+P235 - Store in a well-ventilated place. Keep cool. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
